Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA7 | P43166 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | PLAA | Q9Y263 | 5/20 | 0.53 |
| ▸ | ALPG | P10696 | 6/20 | 0.51 |
| ▸ | ALPL | P05186 | 4/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | DBH | P09172 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29473345 | 1.00 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL7146837 | 0.98 | ALPG (0.54) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL31534576 | 0.98 | ALPG (0.54) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27749561 | 0.83 | MAPT (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27594954 | 0.80 | PKM (0.62) | CA12CA1CA2CA7CA9 | |
| Hydrochloric Acid SCHEMBL11277480 | 0.80 | LCK (0.61) | CA12CA1CA2CA9KDM4E | |
| SCHEMBL1360224 | 0.80 | KDM4E (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL105705 | 0.80 | CA12 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31509307 | 0.80 | CA12 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27868502 | 0.79 | ERN1 (0.54) | GAAL3MBTL1POLBMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4431488-A1 | PREPARATION METHOD FOR DOPAMINE HYDROCHLORIDE | Wuhan Wuyao Pharmaceutical Co., Ltd. (CN) | 2024-09-18 | — | — | EP | claimed |
| CN-107011188-B | Preparation method of isoproterenol hydrochloride | 山东科源制药股份有限公司 | 2020-10-16 | — | — | CN | claimed |
| US-20260124162-A1 | PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION | BAXTER INTERNATIONAL INC. (US) | 2026-05-07 | — | — | US | disclosed |
| CN-121494729-A | Preparation method of (+/-) -norepinephrine | 天方药业有限公司 | 2026-02-10 | — | — | CN | disclosed |
| US-20250195456-A1 | PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION | BAXTER INTERNATIONAL INC. (US) | 2025-06-19 | — | — | US | disclosed |
| US-12290494-B2 | Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation | BAXTER INTERNATIONAL INC. (US) | 2025-05-06 | — | — | US | disclosed |
| CN-119707720-A | Preparation method of norepinephrine hydrochloride | 蚌埠丰原医药科技发展有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20250090483-A1 | PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION | BAXTER INTERNATIONAL INC. (US) | 2025-03-20 | — | — | US | disclosed |
| WO-2025058704-A1 | PROCESS FOR THE PREPARATION OF EPINEPHRINE AND NOREPINEPHRINE | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2025-03-20 | — | — | WO | disclosed |
| CN-116041194-B | Synthesis method of norepinephrine hydrochloride | 武汉武药制药有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-116082173-B | Preparation method of dopamine hydrochloride | 武汉武药制药有限公司 | 2024-11-01 | — | — | CN | disclosed |
| EP-0241901-B1 | Cephalosporin derivatives, processes for their preparation and antibacterial agents | BANYU PHARMA CO LTD (JP) | 1994-08-24 | — | — | EP | disclosed |
| EP-0393782-B1 | Catecholamine esters | ZAMBON SPA (IT) | 1994-08-03 | — | — | EP | disclosed |
| EP-0346465-B1 | 1-CARBOXY-1-VYNILOXYIMINOAMINOTHIAZOLE CEPHALOSPORING DERIVATIVES AND PROCESS FOR THEIR PREPARATION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-08-11 | — | — | EP | disclosed |
| US-5225406-A | Antibiotics | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| US-5084453-A | Antibiotics, bactericides | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1992-01-28 | — | — | US | disclosed |
| US-5061794-A | Effective against pseudomonads | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1991-10-29 | — | — | US | disclosed |
| US-5047592-A | Selective hydrogenolysis process | ETHYL CORPORATION (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0393782-A2 | Catecholamine esters | ZAMBON GROUP S.p.A. (IT) | 1990-10-24 | — | — | EP | disclosed |
| EP-0346465-A1 | 1-CARBOXY-1-VYNILOXYIMINOAMINOTHIAZOLE CEPHALOSPORING DERIVATIVES AND PROCESS FOR THEIR PREPARATION | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1989-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250195456-A1 | PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION | NFE2L2, SLC2A8, ABCG2 | CA12 2805/4885CA1 3278/4885CA2 1856/4885 |
| US-20250090483-A1 | PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION | NFE2L2, SLC2A8, ABCG2 | CA12 2805/4885CA1 3278/4885CA2 1856/4885 |
| US-20260124162-A1 | PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION | SLC6A2, SLC2A4, SLC6A3 | CA12 4072/4885CA1 3976/4885CA2 1893/4885 |
| US-12290494-B2 | Packaged, sealed container system for stable storage of an oxygen sensitive pharmaceutical formulation | NFE2L2, SLC2A8, ABCG2 | CA12 2805/4885CA1 3278/4885CA2 1856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.